TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Lin, Kui ^a   Taylor Jr , James R ^a,b   Wu, Thomas D ^a   Gutierrez, Johnny ^a   Elliott, J Michael ^a   Vernes, Jean Michel ^a   Koeppen, Hartmut ^a   Phillips, Heidi S ^a   de Sauvage, Frederic J ^a   Meng, Y Gloria ^a  

^a GENENTECH INC   (United States)

^b AMERICAN TYPE CULTURE COLLECTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; FOLLISTATIN; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR AA BINDING PROTEIN; PROTEIN TMEFF2; UNCLASSIFIED DRUG; LIGAND; MEMBRANE PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET-DERIVED GROWTH FACTOR A; TMEFF2 PROTEIN, HUMAN; TUMOR PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN CANCER; CELL PROLIFERATION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EMBRYO; EXTRACELLULAR SPACE; FIBROBLAST; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECTUM CANCER; BRAIN TUMOR; DNA MICROARRAY; GENE DELETION; GENE EXPRESSION REGULATION; METABOLISM; OPEN READING FRAME; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

BRAIN NEOPLASMS; CELL PROLIFERATION; DNA METHYLATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOMA; HUMANS; LIGANDS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; PLATELET-DERIVED GROWTH FACTOR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 79955721463     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018608     Document Type: Article

References (53)

1. Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, et al. (1999) A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 Gastric cancer cells. Biochemical and Biophysical Research Communications 266: 593-602.
2. Liang G, Robertson KD, Talmadge C, Sumegi J, Jones PA, (2000) The gene for a novel transmemberane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Research 60: 4907-4912.
3. Young J, Biden KG, Simms LA, Huggard P, Karamatic R, et al. (2001) HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proceedings of the National Academy of Sciences of the United States of America 98: 265-270.
4. Glynne-Jones E, Harper ME, Seery LT, James R, Anglin I, et al. (2001) TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. International Journal of Cancer 94: 178-184.
5. Gery S, Sawyers CL, Agus DB, Said JW, Koeffler HP, (2002) TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. Oncogene 21: 4739-4746.
6. Horie M, Mitsumoto Y, Kyushiki H, Kanemoto N, Watanabe A, et al. (2000) Identification and Characterization of TMEFF2, a Novel Survival Factor for Hippocampal and Mesencephalic Neurons. Genomics 67: 146-152.
7. Afar DEH, Bhaskar V, Ibsen E, Breinberg D, Henshall SM, et al. (2004) Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Molecular Cancer Therapeutics 3: 921-932.
8. Mohler JL, Morris TL, III OHF, Alvey RF, Sakamoto C, et al. (2002) Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. The Prostate 51: 247-255.
9. Belshaw NJ, Elliott GO, Williams EA, Bradburn DM, Mills SJ, et al. (2004) Use of DNA from Human Stools to Detect Aberrant CpG Island Methylation of Genes Implicated in Colorectal Cancer. Cancer Epidemiology Biomarkers & Prevention 13: 1495-1501.
10. Geddert H, Kiel S, Iskender E, Florl AR, Krieg T, et al. (2004) Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not in esophageal and cardiac adenocarcinoma. International Journal of Cancer 110: 208-211.
11. Sato F, Shibata D, Harpaz N, Xu Y, Yin J, et al. (2002) Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res 62: 6820-6822.
12. Shibata DM, Sato F, Mori Y, Perry K, Yin J, et al. (2002) Hypermethylation of HPP1 Is Associated with hMLH1 Hypermethylation in Gastric Adenocarcinomas. Cancer Research 62: 5637-5640.
13. Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, et al. (2005) DNA methylation-associated inactivation of TGF beta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. British Journal of Cancer 93: 1029-1037.
14. Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, et al. (2005) Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 24: 1302-1308.
15. Takahashi T, Shivapurkar N, Riquelme E, Shigematsu H, Reddy J, et al. (2004) Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis. Clinical Cancer Research 10: 6126-6133.
16. Wynter CV, Walsh MD, Higuchi T, Leggett BA, Young J, et al. (2004) Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 53: 573-580.
17. Heldin C-H, Westermark B, (1999) Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor. Physiol Rev 79: 1283-1316.
18. Hoch RV, Soriano P, (2003) Roles of PDGF in animal development. Development 130: 4769-4784.
19. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH, (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and-BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A 89: 1281-1285.
20. Patthy L, Nikolics K, (1993) Functions of agrin and agrin-related proteins. Trends Neurosci 16: 76-81.
21. Patel K, (1998) Follistatin. Int J Biochem Cell Biol 30: 1087-1093.
22. Kupprion C, Motamed K, Sage EH, (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273: 29635-29640.
23. Chang C, Eggen BJ, Weinstein DC, Brivanlou AH, (2003) Regulation of nodal and BMP signaling by tomoregulin-1 (X7365) through novel mechanisms. Dev Biol 255: 1-11.
24. Harms PW, Chang C, (2003) Tomoregulin-1 (TMEFF1) inhibits nodal signaling through direct binding to the nodal coreceptor Cripto. Genes Dev 17: 2624-2629 Epub 2003 Oct 2616.
25. Claesson-Welsh L, Eriksson A, Westermark B, Heldin CH, (1989) cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci U S A 86: 4917-4921.
26. Seifert RA, van Koppen A, Bowen-Pope DF, (1993) PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction. J Biol Chem 268: 4473-4480.
27. Westermark B, Claesson-Welsh L, Heldin CH, (1989) Structural and functional aspects of the receptors for platelet-derived growth factor. Prog Growth Factor Res 1: 253-266.
28. Ross R, Bowen-Pope DF, Raines EW, (1990) Platelet-derived growth factor and its role in health and disease. Philos Trans R Soc Lond B Biol Sci 327: 155-169.
29. Heldin CH, Westermark B, (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
30. Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, et al. (1989) Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264: 8771-8778.
31. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, et al. (1988) cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8: 3476-3486.
32. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
33. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522.
34. Soroceanu L, Kharbanda S, Chen R, Soriano RH, Aldape K, et al. (2007) Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. Proc Natl Acad Sci U S A 104: 3466-3471.
35. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, et al. (2009) Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 1: 177-200.
36. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
37. Huse JT, Phillips H, Brennan C, (2011) Molecular Subclassification of Diffuse Gliomas: Seeing Order in the Chaos. GLIA in press.
38. Phillips DJ, de Kretser DM, (1998) Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 19: 287-322.
39. Lin H, Wada K, Yonezawa M, Shinoki K, Akamatsu T, et al. (2003) Tomoregulin ectodomain shedding by proinflammatory cytokines. Life Sci 73: 1617-1627.
40. Quayle S, Sadar M, (2006) A truncated isoform of TMEFF2 encodes a secreted protein in prostate cancer cells. Genomics 87: 633-637.
41. Ross R, Glomset J, Kariya B, Harker L, (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71: 1207-1210.
42. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, et al. (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219.
43. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, et al. (1996) Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res 56: 164-171.
44. Fudge K, Bostwick DG, Stearns ME, (1996) Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia. Prostate 29: 282-286.
45. Fudge K, Wang CY, Stearns ME, (1994) Immunohistochemistry analysis of platelet-derived growth factor A and B chains and platelet-derived growth factor alpha and beta receptor expression in benign prostatic hyperplasias and Gleason-graded human prostate adenocarcinomas. Mod Pathol 7: 549-554.
46. Katano M, Nakamura M, Fujimoto K, Miyazaki K, Morisaki T, (1998) Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Ann Surg 227: 365-371.
47. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, et al. (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299: 708-710 Epub 2003 Jan 2009.
48. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, et al. (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4: e7752.
49. Calzolari F, Malatesta P, Recent insights into PDGF-induced gliomagenesis. Brain Pathol 20: 527-538.
50. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, et al. (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem 271: 5638-5646.
51. Carey KD, Garton AJ, Romero MS, Kahler J, Thomson S, et al. (2006) Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib. Cancer Res 66: 8163-8171.
52. Polakis P, (2005) Arming antibodies for cancer therapy. Curr Opin Pharmacol 5: 382-387.
53. Kyte J, Doolittle RF, (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.